Which condition is often treated with factor replacement therapy?

Factor replacement therapy is specifically designed to address deficiencies in blood clotting factors, which are critical for proper hemostasis. Von Willebrand disease is a genetic disorder that results in a deficiency or dysfunction of von Willebrand factor, a key protein needed for blood clotting. This deficiency can lead to increased bleeding tendencies.

In treating von Willebrand disease, patients may receive desmopressin, which stimulates the release of stored von Willebrand factor from endothelial cells, or may require factor replacement therapy that provides the necessary clotting factors to improve hemostasis. This targeted approach helps manage bleeding episodes effectively in those affected by the condition.

Other conditions listed do not involve the replacement of clotting factors as part of their treatment protocols. For instance, iron deficiency anemia is addressed with iron supplementation rather than factor replacement. Chronic fatigue syndrome has a different focus in treatment involving symptom management rather than clotting factors. Leukemia treatments typically involve chemotherapy and other modalities, but they do not include factor replacement therapy specifically for blood factor deficiencies.